JPRN-UMIN000014485已完成未知
Golimumab study for development of tight control and biologics-free condition. - Go-sunrising study
Rheumatology, Internal MedicineJuntendo University School of Medicine, Juntendo Koshigaya Hospital0 个研究点目标入组 40 人开始时间: 2014年12月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who have history of allergy for golimumab. 2.Patients who have sepsis, severe infection,active tuberculosin infection, congestive heart disease, active B type viral hepatitis,nontuberculous mycobacterial infection, malignant disorders. 3.Patients who are not adequate for this study judged by investigator of this study.
研究者
相似试验
招募中
4 期
Prospective follow-up study of golimumab treatment in ankylosing spondylitis.1000381610023213Ankylosing SpondylitisNL-OMON41382Jan van Breemen Instituut100
尚未招募
4 期
Prospective follow-up study of golimumab treatment in psoriatic arthritis100038161002321310014982psoriatic arthritisNL-OMON37425Jan van Breemen Instituut100
进行中（未招募）
1 期
Pilot study on the efficacy of golimumab in normalizing the symptoms and lesions of the colon-rectum in patients with ulcerative colitis who only respond to therapy with cortisoneactive steroid-dependent ulcerative colitisMedDRA version: 17.1Level: LLTClassification code 10045365Term: Ulcerative colitisSystem Organ Class: 100000004856EUCTR2014-002579-27-ITIstituto Clinico Humanitas100
已完成
3 期
A Safety and Efficacy Study of Golimumab (CNTO 148) in Patients With Active Rheumatoid Arthritis Despite Methotrexate TherapyRheumatoid ArthritisNCT00727987Janssen Pharmaceutical K.K.269
已完成
3 期
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate TherapyArthritis, RheumatoidNCT00973479Centocor, Inc.592